FierceBiotech 2026-01-16 Vedanta ‘significantly’ reduces headcount to fund lead bacteria cocktail program
FierceBiotech 2026-01-16 JPM26: Chugai chases new science and name recognition from US biopharma industry
FierceBiotech 2026-01-15 Boston Scientific to snap up thrombectomy specialist Penumbra in deal valued at $14.5B
FierceBiotech 2026-01-15 Ocugen posts midphase gene therapy data, charting course for rivalry with Apellis, Astellas
FierceBiotech 2026-01-15 Novo Nordisk Foundation invests $860M in Danish institute nurturing homegrown biotechs
FierceBiotech 2026-01-15 Italy's Alfasigma pens €125M deal for injectable form of German biotech's HSV treatment
FierceBiotech 2026-01-15 JPM26: With pricing deal in the books, Sanofi steels against lingering policy unknowns
FierceBiotech 2026-01-14 JPM26: Leo Pharma, hungry for more partnerships, looks to widen reach in rare dermatology diseases
FierceBiotech 2026-01-14 JPM26: Illumina working with China on 'a path through' its export troubles, sees academic research environment 'muted' for '26
FierceBiotech 2026-01-14 JPM26: As lenacapavir momentum builds, Gilead eyes new deals from a 'position of strength'
FierceBiotech 2026-01-13 Saga Diagnostics expands ultrasensitive blood test to include colorectal cancer
FierceBiotech 2026-01-13 JPM26, Day 2: Amgen touts MariTide's showing in exploratory weight loss maintenance study